Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1988-6-9
|
pubmed:abstractText |
Addition of varying concentrations of HIV-1-seropositive plasma to purified virus particles and soluble viral antigen preparation inhibited the detection of HIV-1-antigen by ELISA. The degree of inhibition on p24 antigen ELISA depended on the relative concentrations of viral antigen and anti-p24 antibodies in the mixtures. The relevance of these observations to clinical specimens was demonstrated when serial plasma samples from nine AIDS-related complex (ARC) patients in a clinical trial of foscarnet therapy were assayed for p24 antigen. Six (66.6%) out of nine patients were negative on screening. However, when their plasma was centrifuged through a sucrose solution, virus particles were pelleted that were depleted of anti-p24 and virus-specific p24 antigen was detected in resuspended pellets obtained from samples from all six patients. Eight serial samples collected from a male homosexual over 50 weeks following seroconversion were also subjected to the separation procedure. HIV-1-antigen was detected in all eight samples. In the light of these observations, the application of the separation technique in monitoring the efficacy of zidovudine or other anti-retroviral therapy should reveal more precise antigen levels in patients who otherwise appear to be antigen-negative in HIV-antigen assays. We propose that the natural history of HIV infections follows a pattern of chronic viral infection with continuous shedding of virus particles circulating as immune complexes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Retroviridae Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3128995-AIDS-Related Complex,
pubmed-meshheading:3128995-Antibodies, Viral,
pubmed-meshheading:3128995-Antigens, Viral,
pubmed-meshheading:3128995-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:3128995-HIV,
pubmed-meshheading:3128995-HIV Antibodies,
pubmed-meshheading:3128995-HIV Antigens,
pubmed-meshheading:3128995-Humans,
pubmed-meshheading:3128995-Retroviridae Proteins,
pubmed-meshheading:3128995-Time Factors,
pubmed-meshheading:3128995-Viral Core Proteins
|
pubmed:year |
1988
|
pubmed:articleTitle |
Restriction of sensitivity of HIV-1-antigen ELISA by serum anti-core antibodies.
|
pubmed:affiliation |
Department of Medical Microbiology, London School of Hygiene and Tropical Medicine, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|